Association of Genome-Wide Variation With the Risk of Incident Heart Failure in Adults of European and African Ancestry
Authors:
- Nicholas L. SmithNSNicholas L. Smith
- Janine F. FelixJFJanine F. Felix
- Alanna C. MorrisonAMAlanna C. Morrison
- Serkalem DemissieSDSerkalem Demissie
- Nicole L. GlazerNGNicole L. Glazer
- Laura R. LoehrLLLaura R. Loehr
- L. Adrienne CupplesLCL. Adrienne Cupples
- Abbas DehghanADAbbas Dehghan
- Thomas LumleyTLThomas Lumley
- Wayne D. RosamondWRWayne D. Rosamond
- Wolfgang LiebWLWolfgang Lieb
- Fernando RivadeneiraFRFernando Rivadeneira
- 1 June 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Genetics
- Vol. 3 (3) , 256-266
Abstract
Background—: Although genetic factors contribute to the onset of heart failure (HF), no large-scale genome-wide investigation of HF risk has been published to date. We have investigated the association of 2 478 304 single-nucleotide polymorphisms with incident HF by meta-analyzing data from 4 community-based prospective cohorts: the Atherosclerosis Risk in Communities Study, the Cardiovascular Health Study, the Framingham Heart Study, and the Rotterdam Study. Methods and Results—: Eligible participants for these analyses were of European or African ancestry and free of clinical HF at baseline. Each study independently conducted genome-wide scans and imputed data to the ≈2.5 million single-nucleotide polymorphisms in HapMap. Within each study, Cox proportional hazards regression models provided age- and sex-adjusted estimates of the association between each variant and time to incident HF. Fixed-effect meta-analyses combined results for each single-nucleotide polymorphism from the 4 cohorts to produce an overall association estimate and P value. A genome-wide significance P value threshold was set a priori at 5.0×10 −7 . During a mean follow-up of 11.5 years, 2526 incident HF events (12%) occurred in 20 926 European-ancestry participants. The meta-analysis identified a genome-wide significant locus at chromosomal position 15q22 (1.4×10 −8 ), which was 58.8 kb from USP3 . Among 2895 African-ancestry participants, 466 incident HF events (16%) occurred during a mean follow-up of 13.7 years. One genome-wide significant locus was identified at 12q14 (6.7×10 −8 ), which was 6.3 kb from LRIG3 . Conclusions—: We identified 2 loci that were associated with incident HF and exceeded genome-wide significance. The findings merit replication in other community-based settings of incident HF.Keywords
This publication has 49 references indexed in Scilit:
- Ubiquitin Proteasome Dysfunction in Human Hypertrophic and Dilated CardiomyopathiesCirculation, 2010
- Multiple loci influence erythrocyte phenotypes in the CHARGE ConsortiumNature Genetics, 2009
- The Rotterdam Study: 2010 objectives and design updateEuropean Journal of Epidemiology, 2009
- Genome-wide association study of blood pressure and hypertensionNature Genetics, 2009
- Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) ConsortiumCirculation: Cardiovascular Genetics, 2009
- Human USP3 Is a Chromatin Modifier Required for S Phase Progression and Genome StabilityCurrent Biology, 2007
- Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot projectNature, 2007
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsNature, 2007
- Principal components analysis corrects for stratification in genome-wide association studiesNature Genetics, 2006
- The framingham offspring study. Design and preliminary dataPreventive Medicine, 1975